Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence

BACKGROUND: Despite regulatory efforts to formalize guidance policies on biosimilars, there remains a need to educate healthcare stakeholders on the acknowledged definition of biosimilarity and the data that underpin it. OBJECTIVES: The objectives of the study were to systematically collate publishe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BioDrugs
Autori principali: Jacobs, Ira, Petersel, Danielle, Shane, Lesley G., Ng, Chee-Keng, Kirchhoff, Carol, Finch, Gregory, Lula, Sadiq
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2016
Soggetti:
Systematic Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5126212/
https://ncbi.nlm.nih.gov/pubmed/27807766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-016-0199-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi